Ocriplasmin Safety Overview from Clinical Trials and Postmarketing Data

被引：0
|
作者：
Lanzetta, Paolo [1 ]
机构：
[1] Univ Udine, I-33100 Udine, Italy
来源：
OPHTHALMOLOGICA | 2014年 / 232卷
关键词：
Ocriplasmin; Vitreomacular Adhesion; Macular Hole; Vitreomacular Traction; OCT;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
192
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [1] Safety profile of oral and intravenous moxifloxacin: Cumulative data from clinical trials and postmarketing studies
    Ball, P
    Stahlmann, R
    Kubin, R
    Choudhri, S
    Owens, R
    [J]. CLINICAL THERAPEUTICS, 2004, 26 (07) : 940 - 950
  • [2] POSTMARKETING SAFETY REPORT ON OCRIPLASMIN THERAPY FOR VITREOMACULAR TRACTION
    Gilhotra, Jagjit
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 : 110 - 110
  • [3] Efficacy and safety of bupropion SR for smoking cessation: Data from clinical trials and five years of postmarketing experience
    Ferry, L
    Johnston, JA
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (03) : 224 - 230
  • [4] Safety of tacrine: Clinical trials, treatment IND, and postmarketing experience
    Gracon, SI
    Knapp, MJ
    Berghoff, WG
    Pierce, M
    DeJong, R
    Lobbestael, SJ
    Symons, J
    Dombey, SL
    Luscombe, FA
    Kraemer, D
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1998, 12 (02): : 93 - 101
  • [5] The need for human data: The role of clinical trials and postmarketing surveillance in the safety assessment of macronutrient substitutes
    Forbes, AL
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1996, 23 (01) : S20 - S21
  • [6] The need for human data: The role of clinical trials and postmarketing surveillance in the safety assessment of macronutrient substitutes - Introduction
    Allgood, G
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1996, 23 (01) : S19 - S19
  • [7] Patient Nonadherence in Clinical Trials: Could There Be a Link to Postmarketing Patient Safety?
    Smith, Dorothy L.
    [J]. DRUG INFORMATION JOURNAL, 2012, 46 (01): : 27 - 34
  • [8] Safety of oral nemonoxacin: A systematic review of clinical trials and postmarketing surveillance
    Yuan, Jinyi
    Zhang, Xiaoping
    Chen, Jing
    Zhang, Yueyuan
    Zhu, Fengjia
    Huang, Haihui
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] On using clinical trials data to predict postmarketing signals of ADRs
    Thakrar, Bharat T.
    Wilcock, Karen S.
    Nevitt, Alan
    DuMouchel, William
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S192 - S192
  • [10] Patient Nonadherence in Clinical Trials: Could There Be a Link to Postmarketing Patient Safety?
    Dorothy L. Smith
    [J]. Drug information journal : DIJ / Drug Information Association, 2012, 46 : 27 - 34
12345